SecBot SecBot

BNR

Burning Rock Biotech Ltd
Nasdaq· Services-Medical Laboratories· CIK 0001792267 Healthcare & Medical Devices
$11.44 −0.38 (−3.26%)
Oct 26 4:00 PM ET · prev $11.82
Market cap
$139.7M
Micro cap
Next earnings
Nov 18
in 23 days
1 year
−2.3%
from $11.70 · Oct 27
30 days
−35.1%
from $17.63
52-week range
$7.04–41.06
−72% from high · low Jun 17
Avg volume 20D
26.6K
Oct 15 spike 73.4K
Short interest
41.4K
≈0.4% of shares · +5.1%
Days to cover
1.0
at average volume
Insider net
+$11.6M
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read BEARISH 2 reports · 90 days
Balance 2 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/2 ·Next Earnings date, Nov 18, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $11.6M at an average $11.13. No open-market sales.

  • InstitutionsBULLISH

    Q2 2026: 4 added (0 new), 0 trimmed or exited.

  • Short sellersSTEADY

    Short interest +5.1% to 41.4K shares. 1.0 days to cover, ≈0.4% of shares.

  • TrendDOWNTREND

    13% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
RENAISSANCE TECHNOLOGIES LLCADD52,838$442.3K
MORGAN STANLEYDOUBLED43,594$364.9K
CITADEL ADVISORS LLCADD27,288$236.6K
UBS Group AGDOUBLED17,916$150.0K
MORGAN STANLEYADD15,272$246.3K
UBS Group AGTRIM408$6.6K
BlackRock, Inc.TRIM4$65.00
MORGAN STANLEYTRIM11,840$238.6K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jul 2021
Recent actions
DateFirmActionRating
Jul 14, 2021CICC
INITIATE
INITIATEOutperform
Jul 13, 2020B of A Securities
INITIATE
INITIATEBuy
Jul 7, 2020Cowen & Co.
INITIATE
INITIATEOutperform

Insider ledger

Form 4
$11.6M
bought · 1 insider
$0
sold · 0 insiders
+2.7%
vs their $11.13 cost
DateInsiderTypeValue
Jun 26, 2026
Han Yusheng
Director
BUY$199.1K
Jun 24, 2026
Han Yusheng
Director
BUY$2.0M
Jun 23, 2026
Han Yusheng
Director
BUY$44.9K
Jun 22, 2026
Han Yusheng
Director
BUY$779.7K
Jun 16, 2026
Han Yusheng
Director
BUY$1000.0K
Jun 12, 2026
Han Yusheng
Director
BUY$1.9M
Jun 11, 2026
Han Yusheng
Director
BUY$216.4K
Mar 31, 2026
Han Yusheng
Director
BUY$5.5M

Earnings setup

Estimates
Nov 18
reports in 23 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
41,425
shares short
+5.1%
vs prior settlement
1.0
days to cover
≈0.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 10, 2026 SEC
Burning Rock reported Q2 2026 revenue of RMB134.7M ($19.9M), a 9.3% YoY decline, with a net loss widening to RMB18.4M…
PRESS-RELEASE — Impact 5/10
Sep 10, 2026 Earnings
Burning Rock Reports Second Quarter 2026 Financial Results
Burning Rock Reports Second Quarter 2026 Financial Results
Sep 10, 2026 SEC
Burning Rock reported Q2 2026 revenue of RMB134.7M ($19.9M), down 9.3% YoY, with net loss widening to RMB18.4M ($2.7M)…
6-K — Impact 5/10
Jun 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
52,838 shares ($442.3K)
Jun 30, 2026 Inst.
MORGAN STANLEY — DOUBLED
43,594 shares ($364.9K)
Jun 26, 2026 Insider
Han Yusheng bought 24,900 shares
Director @ $8.00 ($199.1K)
Jun 24, 2026 Insider
Han Yusheng bought 250,000 shares
Director @ $8.00 ($2.0M)
Jun 23, 2026 Insider
Han Yusheng bought 5,990 shares
Director @ $7.50 ($44.9K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent

SecBot reports

4 filings · 2 press releases · 0 bullish · 4 bearish
All BNR filing & press-release reports (6)